bioRxivNeurosciencePreprint
Huntington's Disease Produces Multiplexed Transcriptional Vulnerabilities of StriatalD1-D2 and Striosome-Matrix Neurons
A. MatsushimaiD, Sergio Sebastian PinedaiD, Jill R. CrittendeniD, Hyeseung LeeiD, Kyriaki Galani, Julio C. ManteroiD, M KellisiD, Myriam HeimaniD, Ann M. GraybieliD
Abstract
Striatal cell-type-specific vulnerability in Huntingtons disease (HD) preferentially affects dopamine D2R-expressing projection neurons (SPNs), compatible with manifest motor symptomatology in HD. Transcriptional studies of striatal striosome-matrix compartmentalization in HD are, however, limited, despite pathologic evidence for striosome vulnerability aligning with early mood symptomatology. We used single-nucleus RNA-sequencing on striatal samples from two murine models, and rare Grade 1 HD patient tissues, to examine striosome and matrix sub-clusters within parent D1 and D2 SPN clusters. In human HD, striosomal SPNs were the most depleted SPN population. Surprisingly, for both mouse models, transcriptomic distinctiveness was diminished more for striosome-matrix SPNs than for D1-D2 SPNs. Compartmental markers were dysregulated so as to cancel endogenous identities as striosomal or matrix SPNs, but markers for D1-D2 exhibited less identity obscuring. The canonical striosome-matrix as well as D1-D2 organizations of the striatum thus are both strongly, but differentially, compromised in HD and are targets for therapeutics.
- organism: mouse
- organism: human
- assay: scRNA-seq
- research focus: differential expression
- research focus: cell type annotation
- research focus: clustering
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-nucleus RNA-seq reveals dysregulation of striatal cell identity due to Huntington’s disease mutations
Sonia Malaiya, Marcia Cortes-Gutierrez, … Seth A. Ament·Journal of NeurosciencePeer-reviewed·May 19, 2021
- Mutant huntingtin expression in the hypothalamus promotes ventral striatal neuropathology
Rana Soylu-Kucharz, Natalie Adlesic, … Åsa Petersén·bioRxiv·Mar 4, 2023
- Temporal single-cell atlas of full-length Huntington's disease mouse model defines stage-specific signatures of corticostriatal dysfunction
Ashley B. Robbins, Paul T. Ranum, … Beverly L. Davidson·Molecular NeurodegenerationPeer-reviewed·May 28, 2026
- Cell-specific transcription dysregulation in human Huntington's disease-positive developing striatum
Sophie V. Precious, Oliver J.M. Bartley, … Anne Rosser·bioRxiv·Jun 19, 2026
- Molecular unbalances between striosome and matrix compartments characterize the pathogenesis of Huntington's disease model mouse
Ryoma Morigaki, Tomoko Yoshida, … Ann M. Graybiel·bioRxiv·Jul 20, 2025
- Transcriptomic Characterization Reveals Disrupted Medium Spiny Neuron Trajectories in Huntington's Disease and Possible Therapeutic Avenues
Carlos Galicia Aguirre, Kizito‐Tshitoko Tshilenge, … Lisa Ellerby·bioRxiv·Apr 30, 2023